AegirBio AB's subsidiary initiates arbitration against Salofa Oy
AegirBio AB’s ("AegirBio" or the "Company") subsidiary Magnasense Technology Oy ("Magnasense") has today decided to initiate arbitration proceedings against Salofa Oy ("Salofa") due to Salofa's failure to comply with its obligations under the agreement entered into on July 7, 2023.AegirBio announced through a press release on July 7, 2023,that a license and distribution agreement was entered into between AegirBio’s subsidiary Magnasense and Salofa whereby Salofa was given access to MagniaReader and MagnetoImmunoAssay (MIA) for its own development of tests in veterinary medicine. Under the